TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26156921

Group type: EXPERIMENTAL
Intervention: Green tea gargling solution (30 cc, gargled every 6 hours for 24 hours)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Distilled water gargling (30 cc, gargled every 6 hours for 24 hours)
Number of subjects: 121
Study: 23354336

Group type: EXPERIMENTAL
Intervention: 0.7 g·kg(‐1) mannitol (group L)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1.4 g·kg(‐1) mannitol (group H)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Midline shift
Number of subjects: 80
Study: 20850351

Group type: EXPERIMENTAL
Intervention: Intraoperative S(+)‐ketamine (0.5 mg/kg as a preincisional bolus followed by a continuous infusion 400 μg/kg/h)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intraoperative S(+)‐ketamine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Perioperative parexocib (40 mg before extubation and 12 hours postoperatively)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ropivacaine alone (subpleural paravertebral infusion)
Number of subjects: 80
Study: 19252905

Group type: EXPERIMENTAL
Intervention: Sodium ibuprofen (512 mg, equivalent to 400 mg ibuprofen acid)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Ibuprofen/poloxamer (400 mg ibuprofen acid and 120 mg poloxamer 407)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Acetaminophen (1000 mg)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Sodium ibuprofen
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Ibuprofen/poloxamer
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Sodium ibuprofen and Ibuprofen/poloxamer
Number of subjects: 322
Study: 17203352

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg given 30 min to 1 hour before biopsy
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg given immediately after biopsy
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 300
Study: 15879863

Group type: EXPERIMENTAL
Intervention: Doxazosin (0.5 mg)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 38
Study: 11678947

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 9623433

Group type: EXPERIMENTAL
Intervention: Sevoflurane 1%
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Sevoflurane 1.5%
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Sevoflurane 1.0%
Number of subjects: 185

Group type: COMPARATOR
Intervention: Propofol 6 mg kg‐1 h‐1
Number of subjects: 185
Study: 8151903

Group type: EXPERIMENTAL
Intervention: Medical therapy for patients with clinically significant LV systolic dysfunction (LV ejection fraction <40%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical therapy for patients with LV dysfunction and normal LV ejection fraction (diastolic dysfunction)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with systolic dysfunction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with symptoms of heart failure
Number of subjects: 0
Study: 3045470

Group type: EXPERIMENTAL
Intervention: 5 Gy, 10 fractions, 2-3 times a week
Number of subjects: 1193

Group type: EXPERIMENTAL
Intervention: 7 Gy, 7 fractions, once in 5 days
Number of subjects: 1193

Group type: EXPERIMENTAL
Intervention: 10 Gy, 4 fractions, once a week
Number of subjects: 1193

Group type: EXPERIMENTAL
Intervention: 5 Gy fractional dose
Number of subjects: 1193
Study: 29688503

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 1852

Group type: COMPARATOR
Intervention: No aspirin
Number of subjects: 1852
Study: 27171537

Group type: EXPERIMENTAL
Intervention: Perceptive rehabilitation treatment with Surfaces for Perceptive Rehabilitation (Su‐Per)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional group physical therapy treatment
Number of subjects: 20
Study: 26173366

Group type: EXPERIMENTAL
Intervention: Social work-led care coordination intervention (one home visit and one to two phone calls)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Usual care post-discharge
Number of subjects: 89
Study: 24152257

Group type: EXPERIMENTAL
Intervention: 20 week after-school dance-based intervention consisting of 40 × 75 minute sessions delivered by external dance instructors
Number of subjects: 594

Group type: COMPARATOR
Intervention: Control schools (no dance intervention)
Number of subjects: 594
Study: 22188731

Group type: EXPERIMENTAL
Intervention: Low dose extrafine BDP/F 100/6 μg (1 actuation)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High dose extrafine BDP/F 100/6 μg (4 actuations)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 17687758

Group type: EXPERIMENTAL
Intervention: HL (hypoxic rooms)
Number of subjects: 11

Group type: COMPARATOR
Intervention: LL (1200 m)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: All subjects pooled
Number of subjects: 11
Study: 16776486

Group type: EXPERIMENTAL
Intervention: Stretching of the plantar fascia
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Calcaneal taping
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Sham taping
Number of subjects: 41
Study: 14651722

Group type: EXPERIMENTAL
Intervention: BUD + FM (budesonide 400 microg + formoterol 12 microg)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: FP + SM (fluticasone propionate 250 microg + salmeterol 50 microg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: BUD + FM
Number of subjects: 29
Study: 10992535

Group type: EXPERIMENTAL
Intervention: Low dose inhaled steroids plus low dose theophylline (LDT, 400 mg daily)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Low dose inhaled steroids (LDS, 200 microgram BDP twice daily)
Number of subjects: 155

Group type: COMPARATOR
Intervention: High dose inhaled steroids (HDS, 500 microgram BDP)
Number of subjects: 155
Study: 8712319

Group type: EXPERIMENTAL
Intervention: Halothane (n = 25)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Isoflurane (n = 26)
Number of subjects: 51
Study: 1999128

Group type: EXPERIMENTAL
Intervention: Postoperative irrigation of the pelvis with saline until effluent was clear.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Drainage alone with all four presacral sump drains placed to suction.
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Positive intraoperative presacral cultures, presence of anaerobes in the presacral space, and duration of pelvic drainage.
Number of subjects: 200
Study: 6318647

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy, radiotherapy, or a combination of both (95% of patients treated according to a randomized trial)
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy in primarily inoperable patients
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Standard surgical procedure (bilateral salpingo‐oophorectomy with or without hysterectomy, and infracolic omentectomy)
Number of subjects: 555
Study: 31370283

Group type: EXPERIMENTAL
Intervention: ESI + E
Number of subjects: 120

Group type: COMPARATOR
Intervention: E
Number of subjects: 120

Group type: COMPARATOR
Intervention: ESI
Number of subjects: 120

Group type: COMPARATOR
Intervention: C
Number of subjects: 120
Study: 29059538

Group type: EXPERIMENTAL
Intervention: Yi Shen Jian Gu granules (YSJG)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study: 27009278

Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplementation 5 g/day for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Coconut oil (CO) control 5 g/day for 8 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Coconut oil (CO) control
Number of subjects: 20
Study: 24293371

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (3 times/week; 3 sets, 6-8 repetitions at 75-80 % of the 1-repetition maximum)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Resistance exercise training
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Reduction in fat mass by 1 kg during resistance exercise training
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Gain in lean body mass by 1 kg during resistance exercise training
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Use of blood cholesterol lowering drugs during resistance exercise training
Number of subjects: 236
Study: 22494946

Group type: EXPERIMENTAL
Intervention: French‐Canadian version of the Wheelchair Skills Training Program (WSTP)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 39
Study: 20004065

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine
Number of subjects: 642

Group type: COMPARATOR
Intervention: Nicotine lozenge
Number of subjects: 642
Study: 17391510

Group type: EXPERIMENTAL
Intervention: Recruitment strategies including payment to practices and reducing workload for referring doctors.
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Employment of an experienced trial co-ordinator and dedicated researchers.
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: National visibility and repeated local publicity by principal investigators.
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Collaboration between primary and secondary care.
Number of subjects: 550
Study: 16027408

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg daily for 4 days
Number of subjects: 44

Group type: COMPARATOR
Intervention: Extended-release oxybutynin chloride 10 mg/d
Number of subjects: 44

Group type: COMPARATOR
Intervention: Extended-release tolterodine tartrate 4 mg/d
Number of subjects: 44
Study: 11684077

Group type: EXPERIMENTAL
Intervention: 200 mg of micronised fenofibrate
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 10 mg of atorvastatin
Number of subjects: 29
Study: 9848522

Group type: EXPERIMENTAL
Intervention: Soy-protein powder at 0, 5, 10, and 20 g/d (0-36 mg isoflavones)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fermented soy products
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Unfermented soy products
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dietary fiber and carbohydrate intake
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Soy challenge
Number of subjects: 60
Study: 8017467

Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg once daily at night
Number of subjects: 123

Group type: COMPARATOR
Intervention: Gemfibrozil 600 mg twice daily
Number of subjects: 123

Group type: COMPARATOR
Intervention: Fluvastatin and Gemfibrozil (comparison)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Fluvastatin and Gemfibrozil (tolerability)
Number of subjects: 123
Study: 2597808

Group type: EXPERIMENTAL
Intervention: Minimal intervention group (further visits to general practitioner for support and monitoring of GGT levels)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Comparison group (advised by general practitioner to cut alcohol consumption)
Number of subjects: 83
Study: 4397654

Group type: EXPERIMENTAL
Intervention: Ritodrine
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 453297

Group type: EXPERIMENTAL
Intervention: TCu 380A
Number of subjects: 1792

Group type: EXPERIMENTAL
Intervention: TCu 300
Number of subjects: 1792

Group type: COMPARATOR
Intervention: TCu 220C
Number of subjects: 1792
Study: 30712748

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation techniques performed once a day for 30 minutes over two months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 80
Study: 27754572

Group type: EXPERIMENTAL
Intervention: Pacifier use
Number of subjects: 70
Study: 25399847

Group type: EXPERIMENTAL
Intervention: Dual Antiplatelet Therapy Study participants
Number of subjects: 1276

Group type: COMPARATOR
Intervention: CathPCI Registry patients
Number of subjects: 1276
Study: 24552494

Group type: EXPERIMENTAL
Intervention: Hypertonic Saline intervention
Number of subjects: 1282

Group type: EXPERIMENTAL
Intervention: Prognostic models
Number of subjects: 1282
Study: 21931376

Group type: EXPERIMENTAL
Intervention: Elevated α‐fetoprotein (AFP)
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Elevated des‐γ‐carboxy prothrombin (DCP)
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Elevated AFP‐L3
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Overall biomarker performance
Number of subjects: 855
Study: 19948623

Group type: EXPERIMENTAL
Intervention: Adherence monitoring with feedback (AMF)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Asthma basic care (ABC)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 250
Study: 17525586

Group type: EXPERIMENTAL
Intervention: HES 130/0.4
Number of subjects: 100

Group type: COMPARATOR
Intervention: hetastarch
Number of subjects: 100
Study: 15149250

Group type: EXPERIMENTAL
Intervention: Verbal working memory tasks
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Visuospatial working memory tasks
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Verbal short-term memory tasks
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Visuospatial short-term memory tasks
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: WM tasks
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: STM tasks
Number of subjects: 236
Study: 11393342

Group type: EXPERIMENTAL
Intervention: Imidapril 5-20 mg
Number of subjects: 349

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 12.5-50 mg
Number of subjects: 349
Study: 9581728

Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg once daily)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 8044491

Group type: EXPERIMENTAL
Intervention: Regular use of earplugs
Number of subjects: 44

Group type: COMPARATOR
Intervention: Hearing loss greater than expected for age matched controls
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Racing experience
Number of subjects: 44
Study: 3176834

Group type: COMPARATOR
Intervention: Midazolam 0.1 mg/kg i.m. as premedication 45 min before induction with midazolam 0.3 mg/kg i.v. (Group 1)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg/kg i.m. as premedication 45 min before induction with thiopentone 4 mg/kg (Group 2)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Calculated i.v. administration curve
Number of subjects: 55
Study: 4753236

Group type: EXPERIMENTAL
Intervention: Oxprenolol 40 mg oral tablet
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31965548

Group type: EXPERIMENTAL
Intervention: Carotegrast methyl (240, 480, or 960 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30723088

Group type: EXPERIMENTAL
Intervention: Learning Together intervention
Number of subjects: 40
Study: 28810669

Group type: EXPERIMENTAL
Intervention: Intervention package
Number of subjects: 372
Study: 25012764

Group type: EXPERIMENTAL
Intervention: Interactive CD-based BLS training programme
Number of subjects: 294

Group type: COMPARATOR
Intervention: Traditional instructor-led BLS training programme
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Both groups (CD and traditional)
Number of subjects: 294
Study: 23864130

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 2737

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2737
Study: 21304925

Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment of malaria (IPTc) with sulphadoxine pyrimethamine plus amodiaquine
Number of subjects: 3014

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3014
Study: 19812459

Group type: EXPERIMENTAL
Intervention: Nurse-led intensive vascular care
Number of subjects: 3700
Study: 17090282

Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg b.i.d.
Number of subjects: 842

Group type: EXPERIMENTAL
Intervention: Tegaserod 2 mg b.i.d.
Number of subjects: 842

Group type: COMPARATOR
Intervention: Placebo-to-tegaserod (switched from placebo to tegaserod 6 mg b.i.d.)
Number of subjects: 842
Study: 15612887

Group type: EXPERIMENTAL
Intervention: SCM‐III 10 mL t.i.d
Number of subjects: 68

Group type: COMPARATOR
Intervention: Heat-inactivated symbiotic
Number of subjects: 68
Study: 11035353

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally 48 hours before operation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally 24 hours before operation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Misoprostol 800 microg vaginally 2 to 4 hours before operation
Number of subjects: 90
Study: 8640072

Group type: EXPERIMENTAL
Intervention: High-dose intravenous thymopentin (TP5) treatment, 1 g three times a week for three patients, 1 g daily for three patients, 2 g daily for two patients
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-dose intravenous thymopentin (TP5) treatment
Number of subjects: 8
Study: 1597660

Group type: EXPERIMENTAL
Intervention: Bifidobacterium bifidum and Lactobacillus acidophilus (Infloran) administered in capsules (two capsules 4 times per day) for 28 days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo administered in the same posology for 28 days
Number of subjects: 15
Study: 2996156

Group type: EXPERIMENTAL
Intervention: Low-dose corticotrophin (ACTH)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 29255011

Group type: EXPERIMENTAL
Intervention: Standard NAS pack
Number of subjects: 909

Group type: COMPARATOR
Intervention: Plain packaging
Number of subjects: 909

Group type: COMPARATOR
Intervention: Australian-like packaging
Number of subjects: 909
Study: 28770596

Group type: EXPERIMENTAL
Intervention: Streamlined care model (ART: efavirenz [EFV]/tenofovir disoproxil fumarate + emtricitabine (FTC) or lamivudine (3TC))
Number of subjects: 972
Study: 24803495

Group type: EXPERIMENTAL
Intervention: Active somatosensory stimulation (SS)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham somatosensory stimulation (SS)
Number of subjects: 33
Study: 23129742

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) followed by surgery and postoperative radiotherapy
Number of subjects: 256

Group type: COMPARATOR
Intervention: Up-front surgery and postoperative radiotherapy
Number of subjects: 256
Study: 21999189

Group type: EXPERIMENTAL
Intervention: Double-dose group (40 mg/Kg TA before and after CPB)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Single-dose group (40 mg/Kg TA before CPB and placebo after CPB)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Double-dose group (TA2)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Double-dose group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 160
Study: 18192495

Group type: EXPERIMENTAL
Intervention: True iontophoresis (TI) with a 40‐mA/min dose of iontophoresis using a 0.4% (4 mg/mL) solution of dexamethasone
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham iontophoresis (SI)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control samples
Number of subjects: 29
Study: 16369107

Group type: EXPERIMENTAL
Intervention: 6-month intervention
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 3-month intervention
Number of subjects: 33
Study: 14666759

Group type: EXPERIMENTAL
Intervention: Nuzhen Yangyin Granule (NYG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10728173

Group type: EXPERIMENTAL
Intervention: Venlafaxine (75 mg/day) plus CBT
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fluoxetine (40 mg/day) plus CBT
Number of subjects: 24
Study: 8554391

Group type: EXPERIMENTAL
Intervention: Flurbiprofen (150 mg IM)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Dipyrone (2 gm) + Hyoscine N-butylbromide (20 mg)
Number of subjects: 135
Study: 1952859

Group type: EXPERIMENTAL
Intervention: Furazolidone at 7 mg/kg/day once
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Furazolidone at 7 mg/kg/day divided into four doses for 3 days
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo once
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo for 3 days
Number of subjects: 118
Study: 7037012

Group type: EXPERIMENTAL
Intervention: Beclobrate (100 mg twice daily)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Eniclobrate (130 mg twice daily)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 31504390

Group type: EXPERIMENTAL
Intervention: Detailed verbal instructions on orthodontic pain and a take-home information leaflet
Number of subjects: 60

Group type: COMPARATOR
Intervention: General verbal information on orthodontic treatment
Number of subjects: 60
Study: 31732214

Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 28
Study: 28649035

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including outreach visits and morbidity/mortality conferences (MMC)
Number of subjects: 165353

Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 165353
Study: 24725729

Group type: EXPERIMENTAL
Intervention: Low-load/high-repetition elastic band resistance training (RT) for 8 weeks, three sessions per week, combined with patient education (four occasions)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group receiving patient education alone
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Low-load/high-repetition elastic band resistance training (RT)
Number of subjects: 44
Study: 24369114

Group type: EXPERIMENTAL
Intervention: 8 Gy in a single fraction
Number of subjects: 425

Group type: COMPARATOR
Intervention: 20 Gy in multiple fractions
Number of subjects: 425
Study: 22951488

Group type: EXPERIMENTAL
Intervention: Daily controls with CBCT
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Daily controls with fiducial markers
Number of subjects: 241

Group type: COMPARATOR
Intervention: Weekly controls with CBCT
Number of subjects: 241

Group type: COMPARATOR
Intervention: Weekly controls with fiducial markers
Number of subjects: 241

Group type: COMPARATOR
Intervention: Daily controls compared to PI with CBCT
Number of subjects: 241

Group type: COMPARATOR
Intervention: Daily controls compared to PI with fiducial markers
Number of subjects: 241